Steinhoff G, Behrend M, Richter N, Schlitt H J, Cremer J, Haverich A
Department of Cardiovascular Surgery, University of Kiel, Germany.
J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1145-55.
Intercellular reactions and cell-matrix interactions are mediated by a number of specific adhesion molecules. For the intravascular reactivity of leukocytes and thrombocytes the endothelial expression of adhesion ligand molecules is of main importance. This condition may be of special relevance for the organ-specific manifestation of immune reactions in heart and lung transplants. The question was investigated as to whether organ-specific differences exist on arterial, venous, and capillary endothelial lining cells in heart and lung transplants and whether this condition is modified during transplant rejection. Transplant biopsy specimens of 24 heart transplant recipients (n = 303) and lung transplant recipients who underwent retransplantation for rejection (n = 4), as well as normal heart (n = 7) and lung tissue (n = 4), were studied. Cell-cell adhesion molecules (intercellular adhesion molecule-1 (CD54) and -2; LFA-3; CD31; vascular cellular adhesion molecule-1; neural cellular adhesion molecule; E-/P-selectin; CD44) and cell-matrix adhesion molecules (very late antigen-1 through -6; CD51) were studied on cryostat sections by means of standard immunohistology.
(1) Arterial, venous, and capilary endothelia in lung and heart tissue show a distinct pattern of cell-cell and cell-matrix adhesion molecules: capillary and venous endothelia are in contrast to arterioles negative for vascular cellular adhesion molecule-1 and P-selectin. Arterial endothelia of the lung, in contrast to veins and capillaries, express no receptors for laminin (very late antigen-2 and very late antigen-6). (2) With transplant rejection, an induction of a number of adhesion molecules was noted on all endothelial lining cells in heart and lung transplants (intercellular adhesion molecule-1[CD54], intercellular adhesion molecule-2, lymphocyte function antigen-3, very late antigen-2, and very late antigen-6). Capillaries of the lung, in contrast to heart capillaries, displayed no inducibility of vascular cellular adhesion molecule-1 and E-selectin. In heart transplants, differences between capillaries and arteriovenous endothelia were found for virus-like agent-2 and -3.
These results show a distinct expression of a both cell-cell and cell-matrix adhesion molecules on arterial, venous, and capillary endothelia of heart and lung transplants. This expression may influence the local regulation of leukocyte and thrombocyte adhesion during transplant rejection. Especially lung capillaries show a lack of inducibility for vascular cellular adhesion molecule-1 and E- and P-selectin required for the induction phase of leukocyte adhesion. This lack was not found in heart transplants. This observation may explain differences in intravascular adhesion and infiltration between vessel compartments in hearts and lungs and could be of relevance for therapeutic interventions to modify leukocyte and thrombocyte adhesion, as during transplant rejection and reperfusion damage.
细胞间反应和细胞与基质的相互作用由多种特定的黏附分子介导。对于白细胞和血小板的血管内反应性而言,黏附配体分子的内皮表达至关重要。这种情况可能与心脏和肺移植中免疫反应的器官特异性表现特别相关。研究了心脏和肺移植的动脉、静脉和毛细血管内皮衬里细胞是否存在器官特异性差异,以及这种情况在移植排斥反应期间是否会发生改变。对24例心脏移植受者(n = 303)和因排斥反应接受再次移植的肺移植受者(n = 4)以及正常心脏(n = 7)和肺组织(n = 4)的移植活检标本进行了研究。通过标准免疫组织学方法,在冷冻切片上研究了细胞间黏附分子(细胞间黏附分子-1(CD54)和-2;淋巴细胞功能相关抗原-3;CD31;血管细胞黏附分子-1;神经细胞黏附分子;E-/P-选择素;CD44)和细胞与基质黏附分子(极迟抗原-1至-6;CD51)。
(1)肺和心脏组织中的动脉、静脉和毛细血管内皮显示出细胞间和细胞与基质黏附分子的独特模式:与小动脉相比,毛细血管和静脉内皮对血管细胞黏附分子-1和P-选择素呈阴性。与静脉和毛细血管相比,肺的动脉内皮不表达层粘连蛋白受体(极迟抗原-2和极迟抗原-6)。(2)随着移植排斥反应的发生,在心脏和肺移植的所有内皮衬里细胞上观察到多种黏附分子的诱导(细胞间黏附分子-1[CD54]、细胞间黏附分子-2、淋巴细胞功能抗原-3、极迟抗原-2和极迟抗原-6)。与心脏毛细血管相比,肺毛细血管未显示血管细胞黏附分子-1和E-选择素诱导性。在心脏移植中,发现毛细血管与动静脉内皮在病毒样因子-2和-3方面存在差异。
这些结果表明,心脏和肺移植的动脉、静脉和毛细血管内皮上细胞间和细胞与基质黏附分子均有独特表达。这种表达可能会影响移植排斥反应期间白细胞和血小板黏附的局部调节。特别是肺毛细血管对白细胞黏附诱导阶段所需的血管细胞黏附分子-1以及E-和P-选择素缺乏诱导性。在心脏移植中未发现这种缺乏情况。这一观察结果可能解释了心脏和肺血管腔室中血管内黏附和浸润的差异,并且可能与在移植排斥反应和再灌注损伤期间改变白细胞和血小板黏附的治疗干预措施相关。